New French look at reimbursement status
This article was originally published in Clinica
The French health ministry has published a list of 14 product groups and services, whose current reimbursement listing status is under threat, as of 2007. The list of products under consideration was published in the Journal officiel of January 20 2006. The list contains generic groups of products and covers some of the following types of products:
You may also be interested in...
The latest drug development news and highlights from the Pink Sheet’s US FDA Performance Tracker.
US FDA’s latest effort to provide guidance for consumers on pharmacogenomics tests underscores the challenges the agency faces in the absence of a clear regulatory framework for lab-developed tests – and with no easy mechanism to update labels for off-patent drugs.